HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF
The present invention provides a method of manufacturing foamable, corticosteroid containing compositions as well as methods for treating various skin diseases.
1 . A storage stable, foamable composition comprising on a weight basis:
a) 0.02 to 0.10% halobetasol or its pharmaceutically acceptable salts, esters, and solvates;
b) 40 to 60% ethyl alcohol;
c) 0.1 to 5.0% Emulsifying Wax, NF;
d) 0.05 to 1.0% cetostearyl alcohol;
e) 0.05 to 1.0% polyoxyl 20 cetostearyl ether;
f) 1 to 10% propylene glycol;
g) 30 to 40% water; and
h) greater than 0.0% and less than 0.0005% benzoic acid,
wherein the composition has a pH of between about 4.0 to 6.3, and
wherein the composition is produced by:
forming a homogenous solution including (b)-(h), wherein the solution is formed in a single batch vessel at a temperature of between about 55° to 75° C. while minimizing the evaporative losses;
cooling the homogenous solution to a temperature of between about 40° to 55° C.;
adding halobetasol, or a pharmaceutically acceptable salt, ester, or solvate thereof, to the cooled solution and forming a homogenous solution while maintaining a temperature of between about 40° to 55° C.;
filling an aerosol canister with the homogenous solution while the solution is maintained at a temperature of between about 40° to 50° C.; and
charging the canister with the propellant thereby forming the foamable composition.
2 . The composition of claim 1 , wherein the ethyl alcohol and benzoic acid are combined before adding the propylene glycol, polyoxyl 20 cetostearyl ether, cetostearyl alcohol and water.
3 . The composition of claim 2 , wherein the benzoic acid is added to the ethyl alcohol which is heated to at least about 55° C. before addition of the benzoic acid.
4 . The composition of claim 1 , wherein the homogenous solution including (b)-(h) is maintained at a temperature of between about 65° to 70° C.
5 . The composition of claim 1 , wherein the homogenous solution including (b)-(h) is cooled to a temperature of between about 45° to 50° C.
6 . The composition of claim 1 , wherein filling is performed while maintaining the solution at a temperature of between about 42° to 48° C.
7 . The composition of claim 1 , wherein the homogenous solution including (b)-(h) is prepared in a suitable vessel to keep evaporative losses below 0.25% w/w during compounding.
8 . The composition of claim 1 , wherein the halobetasol remains stable for at least three months at 40° C.
9 . The composition of claim 1 , wherein the propellant is propane, n-butane, isobutane, or combinations thereof, at 3.25 to 5.75% w/w.